|Podcasts|July 26, 2022
Breaking Barriers Inside and Outside of Clinical Trials
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Otis Johnson, PhD, Vice President, Product Line Executive; Chief Diversity, Inclusion and Sustainability Officer, at Clario discusses key changes in the industry that have had the greatest impact, Clario’s first ESG report, and how DE&I initiatives will evolve.
Related Content
Trending on Applied Clinical Trials Online
1
The Handoff Illusion: Why Clean Transitions in Clinical Development Are a Myth
2
ACT Brief: Inspection Readiness Throughout Lifecycle, AI Churn and Operational Discipline, and Global Trial Stakeholder Alignment
3
ACT Brief: Data Readiness Gap in Continuous Monitoring, Workflow-Centric AI Deployment, and First-in-Class ADHD Mechanism
4
Beyond Compliance: YPrime's Paulo Limgenco on Moving ESG From Reporting to Real Business Value
5